Gouda MA, Duose DY, Lapin M, Zalles S, Huang HJ, Xi Y, Zheng X, Aldesoky AI, Alhanafy AM, Shehata MA, Wang J, Kopetz S , Meric-Bernstam F, Wistuba II, Luthra R, Janku F
Under moderate uracil misincorporation, BER efficiently repairs the damage
"It's more cost effective, and I think that's been the major barrier to getting people these medications, is cost and coverage," Egan said
Others experience optimal results following additional sessions
Bottom line: Your safety is the priority
In this review, we discuss the pipeline of obesity pharmacotherapies with focus on entero-pancreatic hormone-based molecules, and we evaluate the data from early and late phase clinical trials on their safety and efficacy on WL in people with and without T2D